Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort StudyJPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASEIF7.82024-05-013OA
Cerebral phospho-tau acts synergistically with soluble Aβ42 leading to Mild Cognitive Impairment in AAV-AD rats (vol 9, pg 480, 2022)JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASEIF7.82023-01-010OA
Cerebral Phospho-Tau Acts Synergistically with Soluble Aβ42 Leading to Mild Cognitive Impairment in AAV-AD RatsJPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASEIF7.82022-07-017OAAI
Cerebral phospho-tau acts synergistically with soluble Aβ42 leading to Mild Cognitive Impairment in AAV-AD rats (Jan, 10.14283/jpad.2022.18, 2022)JOURNAL OF NUTRITION HEALTH & AGINGIF42022-04-010OA
Evaluation of Memantine in AAV-AD Rat: A Model of Late-Onset Alzheimer's Disease PredementiaJPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASEIF7.82022-04-015OAAI
Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP/PS1 miceACTA NEUROPATHOLOGICA COMMUNICATIONSIF5.72019-03-1834OAAI
Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse modelsSCIENTIFIC REPORTSIF3.92019-03-0837OAAI
Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?NEURAL REGENERATION RESEARCHIF6.72018-01-014OAAI
Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease miceInterleukin-2改善阿尔茨海默病小鼠的淀粉样蛋白病理,突触衰竭和记忆BRAINIF11.72016-12-20149OAAI
Excitation/inhibition balance and learning are modified by Dyrk1a gene dosageNEUROBIOLOGY OF DISEASEIF5.62014-09-01100PREAI
DYRK1A: A master regulatory protein controlling brain growth (vol 46, pg 190, 2012)NEUROBIOLOGY OF DISEASEIF5.62012-08-011OAAI
DYRK1A: A master regulatory protein controlling brain growthNEUROBIOLOGY OF DISEASEIF5.62012-04-01128PREAI